Copyright Reports & Markets. All rights reserved.

Global Protein-based Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Protein-based Therapeutics
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Protein-based Therapeutics by Type
    • 1.3.1 Overview: Global Protein-based Therapeutics Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Protein-based Therapeutics Consumption Value Market Share by Type in 2022
    • 1.3.3 Antibody-based Drugs
    • 1.3.4 Fc Fusion Proteins
    • 1.3.5 Anticoagulants
    • 1.3.6 Blood Factors
    • 1.3.7 Other
  • 1.4 Global Protein-based Therapeutics Market by Application
    • 1.4.1 Overview: Global Protein-based Therapeutics Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Immune Diseases
    • 1.4.3 Cancer
    • 1.4.4 Other
  • 1.5 Global Protein-based Therapeutics Market Size & Forecast
  • 1.6 Global Protein-based Therapeutics Market Size and Forecast by Region
    • 1.6.1 Global Protein-based Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Protein-based Therapeutics Market Size by Region, (2018-2029)
    • 1.6.3 North America Protein-based Therapeutics Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Protein-based Therapeutics Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Protein-based Therapeutics Market Size and Prospect (2018-2029)
    • 1.6.6 South America Protein-based Therapeutics Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Protein-based Therapeutics Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 AbbVie
    • 2.1.1 AbbVie Details
    • 2.1.2 AbbVie Major Business
    • 2.1.3 AbbVie Protein-based Therapeutics Product and Solutions
    • 2.1.4 AbbVie Protein-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 AbbVie Recent Developments and Future Plans
  • 2.2 Johnson & Johnson
    • 2.2.1 Johnson & Johnson Details
    • 2.2.2 Johnson & Johnson Major Business
    • 2.2.3 Johnson & Johnson Protein-based Therapeutics Product and Solutions
    • 2.2.4 Johnson & Johnson Protein-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.3 Novartis
    • 2.3.1 Novartis Details
    • 2.3.2 Novartis Major Business
    • 2.3.3 Novartis Protein-based Therapeutics Product and Solutions
    • 2.3.4 Novartis Protein-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Novartis Recent Developments and Future Plans
  • 2.4 Gilead Sciences
    • 2.4.1 Gilead Sciences Details
    • 2.4.2 Gilead Sciences Major Business
    • 2.4.3 Gilead Sciences Protein-based Therapeutics Product and Solutions
    • 2.4.4 Gilead Sciences Protein-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Gilead Sciences Recent Developments and Future Plans
  • 2.5 Roche
    • 2.5.1 Roche Details
    • 2.5.2 Roche Major Business
    • 2.5.3 Roche Protein-based Therapeutics Product and Solutions
    • 2.5.4 Roche Protein-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Roche Recent Developments and Future Plans
  • 2.6 Bristol-Myers Squibb
    • 2.6.1 Bristol-Myers Squibb Details
    • 2.6.2 Bristol-Myers Squibb Major Business
    • 2.6.3 Bristol-Myers Squibb Protein-based Therapeutics Product and Solutions
    • 2.6.4 Bristol-Myers Squibb Protein-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Bristol-Myers Squibb Recent Developments and Future Plans
  • 2.7 Amgen
    • 2.7.1 Amgen Details
    • 2.7.2 Amgen Major Business
    • 2.7.3 Amgen Protein-based Therapeutics Product and Solutions
    • 2.7.4 Amgen Protein-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Amgen Recent Developments and Future Plans
  • 2.8 AstraZeneca
    • 2.8.1 AstraZeneca Details
    • 2.8.2 AstraZeneca Major Business
    • 2.8.3 AstraZeneca Protein-based Therapeutics Product and Solutions
    • 2.8.4 AstraZeneca Protein-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 AstraZeneca Recent Developments and Future Plans
  • 2.9 Merck & Co
    • 2.9.1 Merck & Co Details
    • 2.9.2 Merck & Co Major Business
    • 2.9.3 Merck & Co Protein-based Therapeutics Product and Solutions
    • 2.9.4 Merck & Co Protein-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Merck & Co Recent Developments and Future Plans
  • 2.10 Takeda
    • 2.10.1 Takeda Details
    • 2.10.2 Takeda Major Business
    • 2.10.3 Takeda Protein-based Therapeutics Product and Solutions
    • 2.10.4 Takeda Protein-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Takeda Recent Developments and Future Plans
  • 2.11 Merck KGaA
    • 2.11.1 Merck KGaA Details
    • 2.11.2 Merck KGaA Major Business
    • 2.11.3 Merck KGaA Protein-based Therapeutics Product and Solutions
    • 2.11.4 Merck KGaA Protein-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Merck KGaA Recent Developments and Future Plans
  • 2.12 Seagen
    • 2.12.1 Seagen Details
    • 2.12.2 Seagen Major Business
    • 2.12.3 Seagen Protein-based Therapeutics Product and Solutions
    • 2.12.4 Seagen Protein-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Seagen Recent Developments and Future Plans
  • 2.13 Eli Lilly
    • 2.13.1 Eli Lilly Details
    • 2.13.2 Eli Lilly Major Business
    • 2.13.3 Eli Lilly Protein-based Therapeutics Product and Solutions
    • 2.13.4 Eli Lilly Protein-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Eli Lilly Recent Developments and Future Plans
  • 2.14 Ono Pharmaceutical
    • 2.14.1 Ono Pharmaceutical Details
    • 2.14.2 Ono Pharmaceutical Major Business
    • 2.14.3 Ono Pharmaceutical Protein-based Therapeutics Product and Solutions
    • 2.14.4 Ono Pharmaceutical Protein-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Ono Pharmaceutical Recent Developments and Future Plans
  • 2.15 Pfizer
    • 2.15.1 Pfizer Details
    • 2.15.2 Pfizer Major Business
    • 2.15.3 Pfizer Protein-based Therapeutics Product and Solutions
    • 2.15.4 Pfizer Protein-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Pfizer Recent Developments and Future Plans
  • 2.16 Regeneron
    • 2.16.1 Regeneron Details
    • 2.16.2 Regeneron Major Business
    • 2.16.3 Regeneron Protein-based Therapeutics Product and Solutions
    • 2.16.4 Regeneron Protein-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Regeneron Recent Developments and Future Plans
  • 2.17 Innovent
    • 2.17.1 Innovent Details
    • 2.17.2 Innovent Major Business
    • 2.17.3 Innovent Protein-based Therapeutics Product and Solutions
    • 2.17.4 Innovent Protein-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 Innovent Recent Developments and Future Plans
  • 2.18 Hengrui Medicine
    • 2.18.1 Hengrui Medicine Details
    • 2.18.2 Hengrui Medicine Major Business
    • 2.18.3 Hengrui Medicine Protein-based Therapeutics Product and Solutions
    • 2.18.4 Hengrui Medicine Protein-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 Hengrui Medicine Recent Developments and Future Plans
  • 2.19 Sanofi
    • 2.19.1 Sanofi Details
    • 2.19.2 Sanofi Major Business
    • 2.19.3 Sanofi Protein-based Therapeutics Product and Solutions
    • 2.19.4 Sanofi Protein-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.19.5 Sanofi Recent Developments and Future Plans
  • 2.20 Sobi
    • 2.20.1 Sobi Details
    • 2.20.2 Sobi Major Business
    • 2.20.3 Sobi Protein-based Therapeutics Product and Solutions
    • 2.20.4 Sobi Protein-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.20.5 Sobi Recent Developments and Future Plans
  • 2.21 Kanghong Pharma
    • 2.21.1 Kanghong Pharma Details
    • 2.21.2 Kanghong Pharma Major Business
    • 2.21.3 Kanghong Pharma Protein-based Therapeutics Product and Solutions
    • 2.21.4 Kanghong Pharma Protein-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
    • 2.21.5 Kanghong Pharma Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Protein-based Therapeutics Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Protein-based Therapeutics by Company Revenue
    • 3.2.2 Top 3 Protein-based Therapeutics Players Market Share in 2022
    • 3.2.3 Top 6 Protein-based Therapeutics Players Market Share in 2022
  • 3.3 Protein-based Therapeutics Market: Overall Company Footprint Analysis
    • 3.3.1 Protein-based Therapeutics Market: Region Footprint
    • 3.3.2 Protein-based Therapeutics Market: Company Product Type Footprint
    • 3.3.3 Protein-based Therapeutics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Protein-based Therapeutics Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Protein-based Therapeutics Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Protein-based Therapeutics Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Protein-based Therapeutics Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Protein-based Therapeutics Consumption Value by Type (2018-2029)
  • 6.2 North America Protein-based Therapeutics Consumption Value by Application (2018-2029)
  • 6.3 North America Protein-based Therapeutics Market Size by Country
    • 6.3.1 North America Protein-based Therapeutics Consumption Value by Country (2018-2029)
    • 6.3.2 United States Protein-based Therapeutics Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Protein-based Therapeutics Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Protein-based Therapeutics Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Protein-based Therapeutics Consumption Value by Type (2018-2029)
  • 7.2 Europe Protein-based Therapeutics Consumption Value by Application (2018-2029)
  • 7.3 Europe Protein-based Therapeutics Market Size by Country
    • 7.3.1 Europe Protein-based Therapeutics Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Protein-based Therapeutics Market Size and Forecast (2018-2029)
    • 7.3.3 France Protein-based Therapeutics Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Protein-based Therapeutics Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Protein-based Therapeutics Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Protein-based Therapeutics Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Protein-based Therapeutics Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Protein-based Therapeutics Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Protein-based Therapeutics Market Size by Region
    • 8.3.1 Asia-Pacific Protein-based Therapeutics Consumption Value by Region (2018-2029)
    • 8.3.2 China Protein-based Therapeutics Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Protein-based Therapeutics Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Protein-based Therapeutics Market Size and Forecast (2018-2029)
    • 8.3.5 India Protein-based Therapeutics Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Protein-based Therapeutics Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Protein-based Therapeutics Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Protein-based Therapeutics Consumption Value by Type (2018-2029)
  • 9.2 South America Protein-based Therapeutics Consumption Value by Application (2018-2029)
  • 9.3 South America Protein-based Therapeutics Market Size by Country
    • 9.3.1 South America Protein-based Therapeutics Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Protein-based Therapeutics Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Protein-based Therapeutics Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Protein-based Therapeutics Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Protein-based Therapeutics Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Protein-based Therapeutics Market Size by Country
    • 10.3.1 Middle East & Africa Protein-based Therapeutics Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Protein-based Therapeutics Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Protein-based Therapeutics Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Protein-based Therapeutics Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Protein-based Therapeutics Market Drivers
  • 11.2 Protein-based Therapeutics Market Restraints
  • 11.3 Protein-based Therapeutics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Protein-based Therapeutics Industry Chain
  • 12.2 Protein-based Therapeutics Upstream Analysis
  • 12.3 Protein-based Therapeutics Midstream Analysis
  • 12.4 Protein-based Therapeutics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Protein-based Therapeutics market size was valued at USD 221660 million in 2022 and is forecast to a readjusted size of USD 420270 million by 2029 with a CAGR of 9.6% during review period.
    Protein therapy is a form of treatment that involves sending in well-structured proteins to a precise target location to repair or replace damaged ones. This is one of the most widely used treatment methods due to its accuracy and lack of negative side effects.
    The Protein-based Therapeutics Market is driven by the increasing demand for innovative biopharmaceuticals that utilize proteins as therapeutic agents to treat a wide range of diseases, including cancer, autoimmune disorders, and rare genetic conditions. Protein-based therapies, such as monoclonal antibodies and recombinant proteins, offer highly targeted and precise treatment options. As scientific advancements and personalized medicine gain prominence, the demand for protein-based therapeutics continues to grow. Innovations in protein engineering, drug development, and manufacturing technologies further contribute to market expansion. However, a significant challenge for this market is the need to address complex drug development processes, high production costs, and regulatory standards while ensuring accessibility and affordability for patients. Overcoming research and development challenges, optimizing drug manufacturing, and adapting to evolving healthcare regulations are ongoing hurdles. Additionally, the market faces competition from small molecules and gene-based therapies, necessitating continuous innovation to unlock the full therapeutic potential of protein-based drugs. Striking a balance between providing safe, effective, and accessible protein-based therapeutics while addressing scientific and regulatory challenges is essential for the continued growth of the Protein-based Therapeutics Market.
    The Global Info Research report includes an overview of the development of the Protein-based Therapeutics industry chain, the market status of Immune Diseases (Antibody-based Drugs, Fc Fusion Proteins), Cancer (Antibody-based Drugs, Fc Fusion Proteins), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Protein-based Therapeutics.
    Regionally, the report analyzes the Protein-based Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Protein-based Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Protein-based Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Protein-based Therapeutics industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Antibody-based Drugs, Fc Fusion Proteins).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Protein-based Therapeutics market.
    Regional Analysis: The report involves examining the Protein-based Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Protein-based Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Protein-based Therapeutics:
    Company Analysis: Report covers individual Protein-based Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Protein-based Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Immune Diseases, Cancer).
    Technology Analysis: Report covers specific technologies relevant to Protein-based Therapeutics. It assesses the current state, advancements, and potential future developments in Protein-based Therapeutics areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Protein-based Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Protein-based Therapeutics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Antibody-based Drugs
    Fc Fusion Proteins
    Anticoagulants
    Blood Factors
    Other
    Market segment by Application
    Immune Diseases
    Cancer
    Other
    Market segment by players, this report covers
    AbbVie
    Johnson & Johnson
    Novartis
    Gilead Sciences
    Roche
    Bristol-Myers Squibb
    Amgen
    AstraZeneca
    Merck & Co
    Takeda
    Merck KGaA
    Seagen
    Eli Lilly
    Ono Pharmaceutical
    Pfizer
    Regeneron
    Innovent
    Hengrui Medicine
    Sanofi
    Sobi
    Kanghong Pharma
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Protein-based Therapeutics product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Protein-based Therapeutics, with revenue, gross margin and global market share of Protein-based Therapeutics from 2018 to 2023.
    Chapter 3, the Protein-based Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Protein-based Therapeutics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Protein-based Therapeutics.
    Chapter 13, to describe Protein-based Therapeutics research findings and conclusion.

    Buy now